Elena Garralda

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.

Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.

Journal: Journal for immunotherapy of cancer

Published: August 03, 2026

Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

Phase 1/2 study of IMC-C103C, a T cell receptor bispecific (MAGE-A4×CD3) ImmTAC targeting MAGE-A4-expressing malignancies.

Journal: Journal for immunotherapy of cancer

Published: July 07, 2026

Quality and safety of research biopsies in oncology clinical trials.

Quality and safety of research biopsies in oncology clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 21, 2026

Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

Journal: Cancer

Published: April 08, 2026

Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.

Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 07, 2026

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 27, 2026

Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.

Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 26, 2026

Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 26, 2026

Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.

Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 26, 2026

Homologous recombination deficiency testing implementation in the routine clinical setting: real-life experience and lessons learned.

Homologous recombination deficiency testing implementation in the routine clinical setting: real-life experience and lessons learned.

Journal: ESMO open

Published: January 22, 2026

From algorithms to meaningful biomarkers: anchoring AI in clinical oncology.

From algorithms to meaningful biomarkers: anchoring AI in clinical oncology.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 07, 2026

Evolving landscape of targeted therapies in early phase clinical trials.

Evolving landscape of targeted therapies in early phase clinical trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 04, 2026

Showing 1-12 of 139

Last Updated: 09/26/2026